Disease response upon cessation of methotrexate in a patient with Hodgkin lymphoma treated with pembrolizumab. Stuver R, Vardhana SA, Bedmutha A, Chan KK, et al. Leuk Lymphoma 2023 Oct 5:1-3. doi: 10.1080/10428194.2023.2262641.

Read + Share

Amedeo Smart

Independent Medical Education

Stuver R, Vardhana SA, Bedmutha A, Chan KK, et al. Disease response upon cessation of methotrexate in a patient with Hodgkin lymphoma treated with pembrolizumab. Leuk Lymphoma 2023 Oct 5:1-3. doi: 10.1080/10428194.2023.2262641.
PMID: 37794809